Poonam Yadav

Poonam Yadav

Auto-generated profile, based on publicly available information

Poonam Yadav

Laboratory of Tumour Immune Microenvironment, Regional Centre for Biotechnology, Third Milestone, Faridabad-Gurgaon Expressway, NCR Biotech Science Cluster, Faridabad 121001, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
KRKajal Rana
Kajal Rana
TPTrishna Pani
Trishna Pani
SJSomesh Kumar Jha
Somesh Kumar Jha
DMDevashish Mehta
Devashish Mehta
PYPoonam Yadav
Poonam Yadav
ABAvinash Bajaj
Avinash Bajaj
Psoriasis is a systemic, relapsing, and chronic autoimmune inflammatory disease of the skin. Topical use of betamethasone, a glucocorticoid, in the form of creams is a common treatment for psoriasis. However, topical use of these creams is challenging due to the ineffective entrapment of steroids, burst release of the entrapped drugs, poor skin permeability, and high toxicity. Herein, we present the engineering of a betamethasone-loaded topical hydrogel (B-Gel) that can efficiently entrap steroids with high spreadability, and can also maintain the sustained release of drugs. We used an imiquimod (IMQ) induced ear psoriasis model, and demonstrated that topical application of B-Gel can mitigate the autoimmune inflammation reactions, and leads to a reduction in erythema, induration, scaling, and ear thickness. As interleukin 17 (IL-17) secreting T helper 17 (Th17) cells and γδ+ T cells are responsible for psoriasis, B-Gel treatment witnessed a reduction in the infiltration of leukocytes, CD4+ T cells, Th17 T cells, and dermal γδ+ T cells. We further demonstrated that B-Gel mediated reduction of IL-1β, IL-17, and K16 (marker for keratinocyte proliferation) is responsible for alleviation of psoriasis. Therefore, the non-greasy nature of the hydrogel with a cooling effect provides an alternative for topical application of steroids.

30 November 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Sreekanth VedagopuramSreekanth Vedagopuram
Sreekanth Vedagopuram
AKAnimesh Kar
Animesh Kar
SKSandeep Kumar
Sandeep Kumar
Sanjay PalSanjay Pal
Sanjay Pal
PYPoonam Yadav
Poonam Yadav
ABAvinash Bajaj
Avinash Bajaj


1 May 2024 in Nanoscale
Verified
Journal Article
Open access
PDF file
PYPoonam Yadav
Poonam Yadav
KRKajal Rana
Kajal Rana
RCRuchira Chakraborty
Ruchira Chakraborty
AKAli Khan
Ali Khan
DMDevashish Mehta
Devashish Mehta
ABAvinash Bajaj
Avinash Bajaj
Tumour cells secrete various proangiogenic factors like VEGF, PDGF, and EGF that result in the formation of highly vascularized tumours with an immunosuppressive tumour microenvironment.

4 February 2025 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
DMDevashish Mehta
Devashish Mehta
CDChhavi Dua
Chhavi Dua
RCRuchira Chakraborty
Ruchira Chakraborty
PYPoonam Yadav
Poonam Yadav
UDUjjaini Dasgupta
Ujjaini Dasgupta
ABAvinash Bajaj
Avinash Bajaj
In this study, we aimed to enhance the tolerability and reduce the toxic effects of DTX by developing a novel hybrid scaffold (PIP-LCA-DTX), where we conjugated DTX to piperidine-derived lithocholic acid.

13 February 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
KRKajal Rana
Kajal Rana
PYPoonam Yadav
Poonam Yadav
RCRuchira Chakraborty
Ruchira Chakraborty
SJSomesh K. Jha
Somesh K. Jha
UAUsha Agrawal
Usha Agrawal
ABAvinash Bajaj
Avinash Bajaj